Search results
Results from the WOW.Com Content Network
Among the bureaus and programs of the Massachusetts Department of Public Health are the following: Bureau of Communicable Disease Control is concerned with areas including tuberculosis prevention and control, sexually transmitted disease prevention, epidemiology, immunization, influenza and West Nile virus monitoring and control, disease quarantine requirements, HIV/AIDS surveillance and ...
The federal Centers for Medicare and Medicaid Services approved the state's waiver application on July 26, 2006, allowing the state to begin enrolling 10,500 people from the waitlist for the MassHealth Essential program, which provides Medicaid coverage to long-term unemployed adults below the poverty line. [40]
The Massachusetts Executive Office of Health and Human Services (EOHHS) is a Cabinet level agency under the Governor of Massachusetts.EOHHS is the largest secretariat in Massachusetts, and is responsible for the Medicaid program, child welfare, public health, disabilities, veterans’ affairs, and elder affairs.
More than 44,000 people are newly enrolled in ConnectorCare, which Morse Gasteier attributed to a two-year pilot program approved in the fiscal 2024 budget that expanded the income eligibility ...
The government has acted swiftly to the recommendations made by the Advisory Council on the Misuse of Drugs (ACMD) and we fully support the banning of 15 new synthetic opioids as Class A drugs.
The Medicare drug list, also called a formulary, lists the prescription drugs and vaccines that Medicare covers. Medicare provides this coverage through Medicare Part D or Medicare Advantage (also ...
The American Society of Health-System Pharmacists (ASHP) reported that 323 "active medication shortages" were reported in January–March 2024. As a result of drug scarcity, many healthcare systems were forced to either ration out essential drugs, triage patients based on the severity of their condition and their need for the drug, or both.
Drug Manufacturer Indication Avacincaptad pegol: To treat geographic atrophy secondary to age-related macular degeneration [4] Cipaglucosidase alfa: To treat late-onset Pompe disease with miglustat [4] Dabrafenib: Dostarlimab: Eflornithine: Elranatamab: To treat relapsed or refractory multiple myeloma after at least four lines of therapy [4 ...